The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma
The aim of this study is to investigate the efficacy and safety of prophylactic central lymph
 node dissection in papillary thyroid carcinoma.
The aim of this study is to investigate the efficacy and safety of prophylactic central lymph
 node dissection in papillary thyroid carcinoma. Primary outcome is the structural recurrence
 rate. Secondary outcomes are operative time, postoperative complications, and quality of
 life.

 The enrolled patients were randomly assigned to control group and intervention group (1:1
 allocation).
Inclusion Criteria:

 -  no clinical and radiological evidence of lymph node metastasis

 -  no evidence of hyperparathyroidism

 Exclusion Criteria:

 -  pregnant women

 -  uncontrolled diabetes, hypertension, or chronic renal failure

 -  aspirin or anticoagulant medication within 7 days

 -  other clinical trial participation within 30 days

 -  radiation exposure to the head and neck

 -  previous operation to the neck

 -  advanced thyroid cancer including adjacent organ invasion